Electroclinical Correlation of Anxiety
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity Hospital, Bordeaux
About this trial
Anxiety disorders have the highest prevalence among mental disorders and cause considerable individual and financial costs. Current treatments do not relieve mental suffering of many patients. Understanding neurobiological mechanisms involved in pathological anxiety is a major scientific challenge.
Eligibility criteria
Qualifiers
Man or woman
Aged 18 to 65;
With drug-resistant epilepsy
Benefiting from a phase II pre-surgical assessment with intracerebral electrophysiological exploration by stereo-EEG
Disqualifiers
Being unable to give personal consent
Be subject to a measure of legal protection (curatorship, guardianship) or placed under judicial protection;
Suffer from a chronic delusional disorder (eg: schizophrenia);
Have a moderate or high risk of suicide assessed using the corresponding section of the structured psychiatric interview called "Mini International Neuropsychiatric Interview" (M.I.N.I. 7.0) or a score > 2 on item 10 of the MADRS, assessing suicidal risk;
Trial design
Treatments tested in this trial
- Anxiety-induced task
- Neuropsychiatric assessment
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
University Hospital, Bordeaux
Lead sponsor
Centre National de la Recherche Scientifique, France
Collaborator
Institut National de la Santé Et de la Recherche Médicale, France
Collaborator
Source ClinicalTrials.gov